Compare AMPH & TDOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | TDOC |
|---|---|---|
| Founded | 1996 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.8M | 1.0B |
| IPO Year | 2005 | 2015 |
| Metric | AMPH | TDOC |
|---|---|---|
| Price | $18.30 | $6.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 18 |
| Target Price | ★ $28.38 | $7.56 |
| AVG Volume (30 Days) | 644.5K | ★ 4.7M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.58 |
| EPS | ★ 0.14 | N/A |
| Revenue | $719,887,000.00 | ★ $2,406,840,000.00 |
| Revenue This Year | $6.90 | $1.19 |
| Revenue Next Year | $4.64 | $1.25 |
| P/E Ratio | $130.00 | ★ N/A |
| Revenue Growth | N/A | ★ 18.41 |
| 52 Week Low | $16.65 | $4.40 |
| 52 Week High | $31.26 | $9.77 |
| Indicator | AMPH | TDOC |
|---|---|---|
| Relative Strength Index (RSI) | 40.00 | 56.48 |
| Support Level | $17.03 | $6.42 |
| Resistance Level | $20.08 | $7.95 |
| Average True Range (ATR) | 0.81 | 0.32 |
| MACD | -0.21 | -0.06 |
| Stochastic Oscillator | 19.16 | 28.76 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.